Kairos Venture Investments, Llc
Venture capitalBeverly Hills · Pre-Seed–Series A · 13 people tracked
Investment thesis
Kairos Ventures invests in ideas, patents, and businesses emerging from the world's top universities and scientists. The firm focuses on scientific and technology innovations with the potential to have a significant, world-changing impact. Led by a group of entrepreneurs with experience building diverse businesses, it positions itself at the intersection of leading financial, scientific, and entrepreneurial expertise, backing early-stage science-driven companies.
Source: firm website, verified Aug 25, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 15 of 33 portfolio companiesBiotech ×8AI & Machine Learning ×4Deep Tech ×4Healthtech ×4Medical Devices ×3New Materials ×3Advanced Manufacturing ×2AgTech ×1
HQs:United States×12
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×43 founders×4
Investments · 33 tracked
founders shown can be your intro path
Clinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.
BiotechFort Worth, US
Daniel Schmitt(Executive Officer, Director)Paul Lytle(Executive Officer)Andrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Co-investorsIllinois VenturesBiosBios Partners
Amorphology manufactures gears and other high-precision metallic components using amorphous metals (Bulk Metallic Glasses), applying additive manufacturing and BMG processing to produce parts with performance advantages over steel or titanium.
Advanced ManufacturingDeep TechNew Materials
Develops novel oncology therapeutics using breakthrough medicinal chemistry technology and biomarker-driven assays to accelerate drug discovery and clinical approval timelines.
Culver City, US
Brian Stoltz(Director)Mark Attanasio(Director)David Chang(Director)David Licata(Director)Dennis Slamon(Director)
Co-investorsOCV Partners
Actinia develops radiation detector materials based on CsPbBr3 (perovskite) semiconductors to improve the resolution and reduce the dose of radiological imaging techniques such as SPECT, CT, and X-ray, with applications in medicine and security.
Deep TechMedical DevicesNew Materials
Mercouri G. Kanatzidis(Founder)Mercouri Kanatzidis(Co-Founder)inDuck Young Chung(Co-Founder)inJosh Palmer(Acting Chief Executive Officer)in
Develops patented technologies for metal manufacturing and material innovation that eliminate traditional machining processes.
Avvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa.
BiotechHardwareHealthtechMedical DevicesSan Francisco, US
Marshall Stoller(Founder (MD))Paul Molloy(Chief Executive Officer & Director)Gregory Johnstone(Executive Officer)Ben Zadik(Executive Officer)Liu Chang(Director)John Garcia(Director)
Co-investorsGlobal Bridge Capital
Biopharmaceutical company harnessing the gut microbiome-central nervous system connection to develop novel therapeutics.
Co-investorsMagic Hour
Behavioral Signals builds Emotion and Voice AI that analyzes tone of voice to detect emotions, behaviors, and intent, and offers a Personalized Agent Intelligent Routing (PAIR) system that matches customers to the best-suited call center agents, along with a deepfake voice detection capability.
AI & Machine LearningEnterprise SoftwareSales Tech
Co-investorsIn-Q-Tel
Clearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSJacksonville, US
Ken Misch(Chief Financial Officer and Chief Operating Officer)Jason Rose(Chief Executive Officer)Matt Henderson(Chief Compliance Officer and General Counsel)Jonathan Cook(Chief Technology Officer)Wirick Glenn(Chief Commercial Officer)Eugene Scheurer(Executive Officer, Director)
Co-investorsHealth Catalyst CapitalHealthQuest Capital
Biopharmaceutical company using molecular biology to produce recombinant derivatives of botulinum neurotoxin for customized applications.
BiotechNew York, US
Charles Weiss(Director)Andre Gudger(Director)Philip A. Band(Executive Officer, Director)Margery Fischbein(Director)
SaaS health tech platform using advanced data analytics to drive disease-specific, coordinated care pathways with streamlined workflows.
Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment.
BiotechHealthtechMedical Devices
Co-investorsUlu Ventures
Company advancing product and clinical development in the medical device space.
Advanced ManufacturingSalt Lake City, US
Frank Maguire(Executive Officer, Director)Mory Gharib(Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)
Co-investorsAngel Physicians FundMemorialCare Innovation FundKairos Venture Partners
Developed the first true wireless power transmission technology enabling previously impossible applications.
Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging.
BiotechHealthtechLongevity
Andrea Choe(CEO / Co-Founder)inPaul W. Sternberg(Co-Founder)Frank C. Schroeder(Co-Founder)
Co-investorsHorizons VenturesBOLD CapitalBold Capital PartnersFREEFLOWEndurance28
Co-investorsThe Colorado Impact Fund
Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.
BiotechHaddonfield, US
Patrick T. Mooney(Executive Officer)James Demetriades(Director)Chris Arendt(Director)Michael D. Poisel(Director)
BoardTodd Thomson(Director)
MattiQ accelerates materials science discovery using a platform for computational experimentation and design across energy, computing, transportation, and space industries.
AI & Machine LearningBiotechDeep TechNew MaterialsChicago, US
Chad A. Mirkin(Executive Officer, Director)Jeffrey Erhardt(Executive Officer, Director)Louis Simpson(Director)
BoardQuinten Stevens(Director)Carmichael S. Roberts(Director)inAlex Andrianapoulis(Director)
Co-investorsMaterial Impact
Charles Fan(Founder)in
Co-investorsCisco InvestmentsFoothill VenturesIntel CapitalLightspeed Venture PartnersTyche Partners
Developing small, cost-effective infrared spectrometer for rapid chemical mixture analysis.
Multi-award-winning 5G mmWave chips offering breakthrough range and efficiency; acquired by Sivers Semiconductors in January 2022.
Chatham, US
Harish Krishnaswamy(Executive Officer, Director, Promoter)Frank Anton Lane(Executive Officer, Director, Promoter)
Provides nanotech coatings offering anti-fogging capabilities in consumer wearables and improved electronic display brightness.
Development-stage biopharmaceutical company focused on therapeutics for neurodegenerative disorders including Alzheimer's and Parkinson's.
Pioneering large-scale nano-architected materials production for diverse applications.
Early-stage ophthalmology company focused on treating ischemic eye diseases like age-related macular degeneration and diabetic retinopathy.
Develops integrated microfluidic technologies for dosing control in handheld vape products using patented breakthrough technologies.
AgTechSanta Monica, US
Frances Arnold(Director)Peter Meinhold(Executive Officer)Pedro Coelho(Executive Officer)Corey Huck(Executive Officer, Director)
BoardGANESH KISHORE(Director)inALAN BOYCE(Director)
Co-investorsAliment CapitalPontifax AgTechSpruce Capital PartnersVivo CapitalKairos Venture PartnersXeraya Capital
PteroDynamics designs autonomous vertical takeoff and landing (VTOL) aircraft built around its patented Transwing folding-wing system, which combines fixed-wing speed and range with VTOL capability for delivering cargo and ISR payloads to remote locations without runways.
Defense TechRoboticsMoorpark, US
Matthew Graczyk(CEO)
Co-investorsLavrock Ventures
Developing rapid, point-of-care diagnostic tool with single-molecule precision for identifying diverse analytes.
Develops technologies improving combustion and reacting flow processes for energy, aerospace, and defense applications.
Develops nanosecond pulsed power systems that increase fuel efficiency and reduce emissions significantly.
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.
AI & Machine LearningBiotechDeep TechBrisbane, US
Andrei Georgescu(Executive Officer, Director)Dongeun Huh(Executive Officer, Director)Andrei Georgescu, Ph.D.(Founder)in
BoardQuinten Stevens(Director)Alex Andrianopolous(Director)Alex Morgan(Director)in
Co-investorsBison VenturesKhosla VenturesFortius VenturesMBX Capital
Revolutionizing the razor blade industry with proprietary Bulk Metal Glass technology in partnership with Kairos portfolio company Amorphology.
Exits · 2
IPOs and acquisitions across the tracked portfolioActuate TherapeuticsNASDAQ: ACTUMixCommacq. by Sivers Semiconductors
Portfolio news
latest coverage across their companies
Actuate Therapeutics · stocktitan.net · Aug 14, 2026
Provivi · trysignalbase.com · Jun 11, 2026
Linnaeus Therapeutics · technical.ly · Mar 10, 2026
Mattiq · cen.acs.org · Nov 10, 2025
Holoclara · holoclara.com · Aug 28, 2025
Vivodyne · pci.upenn.edu · Jul 8, 2025
Avvio Medical · avviomedical.com · Jun 19, 2025
Frequently asked questions
- How many investments has Kairos Venture Investments, Llc made?
- Kairos Venture Investments, Llc has 32 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Kairos Venture Investments, Llc invest at?
- Kairos Venture Investments, Llc invests at the Pre-Seed, Seed, Series A stages.
- What is Kairos Venture Investments, Llc's typical check size?
- Kairos Venture Investments, Llc typically writes checks of $150K – $20M.
- What sectors does Kairos Venture Investments, Llc focus on?
- Kairos Venture Investments, Llc focuses on Biotech, Deep Tech, Energy, Medical Devices, Mobility & Transportation, New Materials, Robotics, Sector Agnostic.
- Where is Kairos Venture Investments, Llc located?
- Kairos Venture Investments, Llc is headquartered in Beverly Hills, US.
- Does Kairos Venture Investments, Llc lead rounds?
- Yes, Kairos Venture Investments, Llc leads investment rounds.
- Who does Kairos Venture Investments, Llc co-invest with?
- Kairos Venture Investments, Llc most often shares deals with Bold Capital Partners, Horizons Ventures, Intel Capital, among 23 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Seafund is an early-stage venture capital firm that backs startups building in deeptech and deepscience, providing hands-on support alongside capital.
Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.